This Makes NVIDIA Nervous

NVIDIA's AI chips use huge amounts of power. But a new chip could cut energy use by 99% and run 10 million times more efficiently. One U.S. company has cornered this market. They control the first commercial foundry in America. At under $20 a share, it's a ground-floor shot at the next tech giant.

ARWR
Arrowhead Pharmaceuticals Inc
NASDAQ
36.81
Open 38.20 Prev Close 38.97
High 39.36 Low 36.57
Volume 1,877,816 Volume (Avg) 2,506
52 Week High 40.29 52 Week Low 9.57
Market Cap 5.1B PE Ratio

About Arrowhead Pharmaceuticals Inc

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's product pipeline includes Plozasiran, which has completed Phase 3 clinical trial to treat hypertriglyceridemia, dyslipidemia, and familial chylomicronemia syndrome; Olpasiran that is in Phase 3 clinical trial to reduce the production of apolipoprotein A; and Fazirsiran that is in Phase 3 clinical trial for the treatment of liver disease associated with alpha-1 antitrypsin deficiency. It also develops Zodasiran that is in Phase 2b clinical trial for the treatment of dyslipidemia and hypertriglyceridemia; GSK-4532990 to treat metabolic-dysfunction associated steatohepatitis (MASH); and Daplusiran/Tomligisiran which is in Phase 2 clinical trial for the treatment of Chronic Hepatitis B. In addition, the company is developing ARO-PNPLA3, which is in Phase 1 clinical trial to treat patients with MASH; ARO-INHBE to reduce the hepatic expression of the INHBE gene and its secreted gene product; ARO-RAGE to treat inflammatory lung disease; ARO-MUC5AC to treat muco-obstructive pulmonary diseases; and ARO-MMP7 for the treatment of idiopathic pulmonary fibrosis that is in Phase 1/2a clinical trials. Further, it develops ARO-DUX4 for the treatment of facioscapulohumeral muscular dystrophy; ARO-DM1 to treat patient with Type 1 Myotonic Dystrophy; ARO-C3 to treat complement-mediated renal disease; ARO-CFB for the treatment of complement-mediated kidney disease that is in Phase 1/2a clinical trial; and ARO-ATXN2 for the treatment of Spinocerebellar Ataxia Type 2 that is in Phase 1 clinical trial. Arrowhead Pharmaceuticals, Inc. has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Horizon Therapeutics Ireland DAC; Takeda Pharmaceutical Company Limited; and with Amgen Inc. The company was founded in 2003 and is headquartered in Pasadena, California.

General

NameArrowhead Pharmaceuticals Inc
TickerARWR
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CurrencyUSD
CountryUSA
Fiscal Year EndSeptember
Full Time Employees609

Highlights

Analyst Target43.00
Market Cap5,089,300,000
PEG Ratio-1.32
EBITDA-85,396,000

Share Stats

Shares Outstanding138,140,000
Shares Float128,360,000
Shares Short11,700,000
Insider Holdings441%
Institution Holdings78.05%

Highlights

Analyst Target43.00
Market Cap5,089,300,000
PEG Ratio-1.32
EBITDA-85,396,000

Valuation

Forward PE111.11
Price/Sales (Trailing 12 Mt.)9.40
Price/Book (Most Recent Quarter)9.16

Earnings

Most Popular

Steve Wozniak's Favorite Steve Jobs Movie Was A 1999 Release That Never Made It To The Cinemas: Here's Why He Loved Watching It

Apple Inc. (NASDAQ: AAPL) co-founder Steve Wozniak says Hollywood has captured Steve Jobs' best not in the splashy 2013 biopic starring Ashton Kutcher, "Jobs," but in a lower-profile 1999 made-for-TV film, "Pirates of Silicon Valley."

Trump Commutes Former Rep. George Santos' Seven-Year Prison Term: '... Has Been Horribly Mistreated'

President Donald Trump announced on Friday that he commuted the prison sentence of former congressman George Santos (R-N.Y.), ordering his immediate release.

This Company Could Challenge NVIDIA's Reign - Ad

This new chip can run at the speed of light and it's changing the game. "TF3" could replace silicon entirely and one American company is producing it commercially. Clients already include NASA and top medical research institutions. It's still under the radar - and that's the opportunity.

Indiana University fires student newspaper adviser who refused to block news stories

Tension between Indiana University and its student newspaper flared this week with the elimination of the outlet's print editions and the firing of a faculty adviser, who refused an order to keep news stories out of a homecoming edition.

Elon's New Device Could Launch Biggest IPO of the Decade - Ad

Elon Musk's new device is being called a "game-changer"-and even the White House is using this tech. Jeff Brown says it could launch Musk's next trillion-dollar company and make early investors rich. You can claim a stake now for as little as $500.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

Analyst See Noise In Q3 P&L, Affirms Abbott's Medtech Strength

Abbott eyes 10% EPS growth in 2026 with CGM momentum, new nutrition contracts, and medical device launches driving global expansion.

Macron is set to appoint a new French prime minister in last-ditch move to tackle turmoil

PARIS (AP) — After a week of intense political turmoil, French President is set to appoint a new prime minister Friday in his latest bid to break the political deadlock that has gripped the country for more than a year, as France struggles with mounting economic challenges and ballooning debt.

Oct 23: The Day Elon Changes Everything - Ad

Mark your calendar: October 23, 2025. That's the date I believe Elon Musk could finally unveil his Optimus robot - the same project he says will be "the biggest product ever of any kind." If Elon is right, this could be a $30 trillion tipping point...And regular investors have a rare window to move before the switch flips.

Pam Bondi Says Meta Removed Facebook Page Used To 'Dox And Target' ICE Agents: 'Wave Of Violence' Against ICE Driven By Online Apps

Meta removed a Facebook page accused by the Justice Department of being used to "dox and target" ICE agents in Chicago, following similar actions by Apple and Google amid rising controversy over President Donald Trump's immigration enforcement tactics.

Billionaire Makes $72 Million On Trilogy Metals Stock—Here's What Else He's Holding

Billionaire hedge fund manager John Paulson has scored extraordinary gains with Trilogy Metals—he's also holding gold miners.

On October 16, a powerful new law signed by President Trump will trigger a radical shift in America's money system... - Ad

When a small group of private companies - not the Fed - will perform a major mint of a new kind of money. And those who act before this new system fully kicks in could see gains as high as 40X by 2032. But those who fail to prepare will be blindsided by this sea change to the U.S. dollar.

Demand For Electric Pickup Trucks Soar In Q3, Except If You're Tesla

New data shows the top-selling EV brands and companies for the U.S. in the third quarter. Strong demand for electric pickup trucks benefits several companies.

Ethereum Crashes To $4,100 As Senate Democrats Take Aim At DeFi

Ethereum (CRYPTO: ETH) is trading near $4,100 on Friday, after a sharp selloff that followed its rejection from $4,700 and renewed fears of U.S.

Why Are Wall Street Insiders Moving Their Money to This One Asset? - Ad

Something far more consequential for your money than tariffs is unfolding behind the scenes... Tucked inside this overlooked directive is a plan set to be executed for the first time in in U.S. history. One Stansberry Research's Senior Partner says it's set to trigger a rare window for potentially explosive gains in ONE asset immediately. (Not AI or crypto). Wall Street insiders are already positioning themselves... and he insists you should, too, before it's too late.

China shows no sign of backing down while issuing call for US to withdraw tariff threat

BANGKOK (AP) — China did not back down Monday in a back-and-forth with the U.S. over trade, calling for U.S. President Donald Trump to withdraw his latest threat of a 100% tariff and other export control measures announced over the weekend.

Trump Ally Laura Loomer Turns on Him Over Qatar Military Base Plan, Calls It a 'Betrayal'

Laura Loomer, a staunch supporter of President Donald Trump, has voiced her dissatisfaction with the president's decision to permit a Qatari air force facility in Idaho.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Magnolia Oil & Gas Gets Upgrade On Strong Finances, Brighter Oil Outlook

KeyBanc raised Magnolia Oil & Gas to Overweight with a $29 target, citing a defensive profile and disciplined growth outlook.

November 18: D-Day For The Dollar - Ad

A quiet shift in U.S. law has just authorized private companies to mint a new form of government-authorized money called the "Dollar 2.0"... and the next major mint hits on November 18. Investors who make the right moves before then could make up to 40X by 2032...

Donald Trump's Looming Shutdown Could Trigger Mass Layoffs, Slash Regulations and Deploy Troops

President Trump administration is preparing for a potential government shutdown that could lead to thousands of federal employees being laid off and significant changes in the functioning of various departments.

Trump approves Alaska mining road to boost copper, zinc production

WASHINGTON (AP) — President Donald Trump on Monday ordered approval of a proposed 211-mile road through an Alaska wilderness to allow mining of copper, cobalt, gold and other minerals.

[Revealed] Trump's Next AI Executive Orders? - Ad

A White House insider with direct ties to Trump's inner circle just revealed what he calls "Manhattan II" - a potential $2.2 trillion AI initiative. He says this could mirror past U.S. projects that minted fortunes - with small firms soaring 5,000% to 10,000% over two decades. And now he's giving away his #1 stock pick for free before the deadline.

Nebius Vs. Palantir: The AI Infrastructure War At 100x Sales

Wall Street's AI mania has sparked a battle between Nebius (NBIS) and Palantir (PLTR) as investors question where the true value of AI lies.

Regeneron's Gene Therapy Shows Significant Gains In Genetic Hearing Loss

Regeneron gene therapy for OTOF-related hearing loss shows rapid, sustained improvements, including normal hearing in some participants.

This Makes NVIDIA Nervous - Ad

NVIDIA's AI chips use huge amounts of power. But a new chip could cut energy use by 99% and run 10 million times more efficiently. One U.S. company has cornered this market. They control the first commercial foundry in America. At under $20 a share, it's a ground-floor shot at the next tech giant.

Can a Taxable Account Beat a 401(k)?

Being advised to max out your 401(k)is Personal Finance 101. But is that universally solid guidance?

Retail Investors Gain Access To Private Credit Market Via This New ETF

Simplify Asset Management and VettaFi have introduced a new exchange-traded fund (ETF) that enables retail investors to tap into the rapidly growing private credit market.

This Company Could Challenge NVIDIA's Reign - Ad

This new chip can run at the speed of light and it's changing the game. "TF3" could replace silicon entirely and one American company is producing it commercially. Clients already include NASA and top medical research institutions. It's still under the radar - and that's the opportunity.

Apple iPhone 17 Pro, Pro Max Ship Times Stay Stable Globally: Analyst

Apple's iPhone 17 Pro and Pro Max maintain stable lead times globally, while the iPhone Air is widely available. Analyst maintains Buy rating with $270 price target.

Trump administration puts on hold $18 billion in funding for New York City infrastructure projects

WASHINGTON (AP) — President Donald Trump's administration said Wednesday it was putting a hold on roughly $18 billion to fund beneath the Hudson River between New York City and New Jersey and the city's expanded project because of .

Elon's New Device Could Launch Biggest IPO of the Decade - Ad

Elon Musk's new device is being called a "game-changer"-and even the White House is using this tech. Jeff Brown says it could launch Musk's next trillion-dollar company and make early investors rich. You can claim a stake now for as little as $500.

Boeing's 737 Momentum Fuels Delivery Surge, Embraer Stays On Track

Commercial aerospace regains altitude in Q3 as Boeing, Embraer, and Airbus show improving production stability and rising delivery momentum.

Tesla Diner Served 50,000 Burgers Last Quarter, While The Company Saved 842 Million Liters Of Gas

Tesla shares stats of its Supercharger locations and its Tesla Diner for the third quarter. A look at some of the surprises and daily rates.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

Why American Airlines (AAL) Stock Is Falling Thursday

Shares of American Airlines are trading lower Thursday afternoon in sympathy with competitor United Airlines.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright technicaltrading.org
Privacy Policy | Terms of Service